Society of Nuclear Medicine and Molecular Imaging (SNMMI)

Register today for the 2024 SNMMI Annual Meeting in Toronto

The 2024 Annual Meeting will be offered as a fully hybrid event with both in-person and remote registration and attendance options available to best suit your personal needs. Both options give you access to live-streamed sessions to watch virtually as they happen and all sessions on-demand following the meeting for 90 days! Register Today!

"Alpha is More Than Just Ac-225: Pb-212” is the newest episode of the JNM Podcast. Listen now as our panel of experts discuss the logistics of using lead-212 as a radionuclide imaging agent.

The world of work is changing. Every day, new innovations are released into the market that impacts the work we do and how we do it. This documentary series takes a closer look at the modernization and change-makers who are shaping the future of work--including in the field of nuclear medicine! Watch Jobs of Tomorrow--today!

SNMMI's cohort of Technologist Fellows talk about their nuclear medicine career journeys, future goals, and favorite parts of the profession in a series of video interviews. Watch now!

A new PET imaging agent yielded high-quality PET scans of metastatic ccRCC tumors in as little as one hour. Read more in the May 2024 issue of The Journal of Nuclear Medicine. Read now!

SNMMI NEWS

May 29, 2024 — UPTAKE: Meet the Fellows!
Tommy Lieu interviews 3 of SNMMI's TS Fellows about their careers, goals, and favorite parts of their jobs. (SNMMI News)
May 21, 2024 — Reflections on My Henkin Fellowship
Joseph Steiner, PhD DABR, reflects on his recent experience as the 2024 SNMMI Henkin Fellow. (Government Relations News)
May 7, 2024 — Newly Identified PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
The protein galectin-1 has been identified as a new PET imaging biomarker for immune checkpoint blockade therapy, allowing physicians to predict the tumor responses before beginning treatment, according to new research published in JNM. (Press Releases)
May 7, 2024 — New PET Agent Provides Exceptional Same-Day Imaging for Clear Cell Renal Cell Carcinoma Patients
A novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer patients according to new research published in the May issue of JNM. (Press Releases)
May 6, 2024 — JNM Supplement Highlights Nuclear Medicine Innovation in China
A new JNM supplement spotlights the role China has played in advancing global nuclear medicine, detailing significant advances in research and development as well as the clinical translation of novel radiopharmaceuticals. (Press Releases)
April 25, 2024 — FDA Approves Lu-177 DOTATATE for Pediatric Patients with GEP-NETS
The FDA has approved lutetium-177 DOTATATE for pediatric patients 12 years and older with somatostatin receptor–positive gastroenteropancreatic neuroendocrine tumors. (SNMMI News)
April 16, 2024 — New SPECT/CT Technique Shows Impressive Biomarker Identification, Offers Increased Access for Prostate Cancer Patients
A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment, according to new research in JNM. (Press Releases)
April 15, 2024 — Nuclear Medicine Funding Language in CDRMP
SNMMI is excited to share that with the signing H.R. 2882, which included the FY 2024 Defense Appropriations bill, SNMMI’s CDMRP report language has been approved. (Government Relations News)

CONTINUING EDUCATION

New! ASNC/SNMMI 80 Hour Authorized User Training Course

The new online ASNC/SNMMI 80 Hour Authorized User Training Course is designed to provide nuclear medicine physicians with the knowledge needed to establish a culture of safety and quality in their practice. Learn More »

New! SNMMI Qualified Systems Personnel Training Program (QSPTP)

The SNMMI Qualified Systems Personnel Training Program (QSPTP) has been developed to define the competencies of a Qualified Person in the release of manufactured radiopharmaceuticals, providing experts in the field of radiopharmaceutical science guidance in program development. Learn More »

SNMMI Webinars

Access upcoming and recorded webinars from the new SNMMI Webinars website. Learn More »

Nuclear Medicine Online Review Course

Covering the most essential topics in nuclear medicine—you'll build the level of expertise you need to ace your exam! AMA PRA Category 1 credits available. Learn More »

Radiation Safety+ Review and Essentials

The Radiation Safety+ Review and Essentials program provides a comprehensive overview of all aspects of radiation safety for nuclear medicine technologists preparing to take the NMTCB’s Radiation Safety Certification Examination. Learn More »

CT+ Review and Essentials

CT+ Review and Essentials provides you with the comprehensive didactic education you need to succeed, whether you're looking to build your general CT knowledge, or preparing to sit for the ARRT (CT) and/or NMTCB (CT) exam(s). Learn More »

Member Benefit! Complimentary Journal SAMs/Journal CE

Free Journal SAM/CE access is available exclusively for SNMMI Members. Take advantage of this great benefit and meet your certification requirements. Learn more »

PUBLICATIONS

Journal of Nuclear Medicine

VIEW CURRENT ISSUE
Journal of Nuclear Medicine Technology

VIEW CURRENT ISSUE
Molecular Imaging
Journal

VIEW CURRENT ISSUE

FEDERAL LEGISLATIVE EFFORTS

The FIND Act – Learn more »

MOLECULAR IMAGING NEWS

May 31, 2024

EDUCATION AND RESEARCH FOUNDATION

ERF secures, invests and distributes funding to support rigorously vetted physicians, scientists and technologists in the pursuit of advanced academic studies or breakthrough discoveries in the field. Learn More »